News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xeris Pharmaceuticals Closes US$1.5 Million Series A Financing with Central Texas Angel Network



12/12/2011 8:14:27 AM

AUSTIN, Texas--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc., a biopharmaceutical company developing the G-Pen™, a glucagon rescue pen for emergency treatment of severe hypoglycemia, has completed a Series A preferred stock financing for approximately $1.5 million. The financing was led by the Central Texas Angel Network (CTAN), with significant participation of life science investors including family offices from California and Tennessee.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES